XENON PHARMACEUTICALS INC (XENE:NASDAQ)
$59.7 1.27 (2.1735%)
Analysed XENON PHARMACEUTICALS INC (XENE:NASDAQ) News Sources
Xenon to Present at Upcoming Investor Conferences
15-04-2026
yahoo.com
Xenon to Highlight Phase 3 X-TOLE2 & Long-Term Data for Azetukalner in Focal Onset Seizures at 2026 AAN Annual Meeting
07-04-2026
yahoo.com
Xenon Pharma Stock Up 55% as Insider Sells $78K in Shares. Here's What Investors Should Know
27-03-2026
fool.com
Xenon Pharmaceuticals Stock Soars 20% in 3 Months: Here's Why
19-03-2026
yahoo.com
Xenon Pharmaceuticals (XENE) Is Down 6.7% After $650 Million Follow-On Offering And Phase 3 Epilepsy Win
18-03-2026
yahoo.com
Xenon Pharmaceuticals (XENE) Climbs 31.7% as Epilepsy Treatment Moves Forward
15-03-2026
yahoo.com
This Fund Has a $200 Million Bet on a Biotech Stock Up 30% in Days After Phase 3 Breakthrough
13-03-2026
fool.com
Battery Storage Stock Up 50% in a Year Draws New $110M Investment. Here's What You Should Know
13-03-2026
fool.com
Biotech Stock Up 685% Draws $80.5 Million Investment Amid Dual FDA Filings
13-03-2026
fool.com
Assessing Xenon Pharmaceuticals (XENE) Valuation After A Sharp Recent Share Price Surge
12-03-2026
yahoo.com
What is the current price of XENON PHARMACEUTICALS INC (XENE:NASDAQ)?
The current price of XENON PHARMACEUTICALS INC (XENE:NASDAQ) is $59.7.
XENON PHARMACEUTICALS INC (XENE:NASDAQ) absolute price change since previous trading day?
The absolute price change of XENON PHARMACEUTICALS INC (XENE:NASDAQ) since the previous trading day is $1.27.
XENON PHARMACEUTICALS INC (XENE:NASDAQ) percentage price change since previous trading day?
The percentage price change of XENON PHARMACEUTICALS INC (XENE:NASDAQ) since the previous trading day is 2.1735%.
What is the most recent average sentiment score for XENON PHARMACEUTICALS INC (XENE:NASDAQ)?
The most recent average sentiment score for XENON PHARMACEUTICALS INC (XENE:NASDAQ) is 89 out of 100.
What is the most recent average sentiment for XENON PHARMACEUTICALS INC (XENE:NASDAQ)?
The most recent sentiment for XENON PHARMACEUTICALS INC (XENE:NASDAQ) is .
SEC-8K** Filing Available For XENON PHARMACEUTICALS INC (XENE:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.